Diagnostic and Interventional Cardiology

Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, USA, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial to evaluate the potential benefits of a Direct to Angio Suite treatment pathway for stroke patients

First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment

July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter ...

July 20, 2023

A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical protocol for cardiovascular computed tomography (CCT) to guide intervention in the right ventricular outflow tract (RVOT) in patients with congenital heart disease (CHD).

News | Computed Tomography (CT)

Optimal CHD Patient Care Requires Interventional, Surgical Collaboration

July 20, 2023 — A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical ...

July 20, 2023

Feature | SCCT | Christine Book

Society of Cardiovascular Computed Tomography (SCCT) Sets Stage for 18th Annual Scientific Meeting, SCCT 2023

July 20, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) is preparing for its 18th Annual Scientific ...

July 20, 2023

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

The future is quite promising for TAHs, but it will be a decade or more before they may become a comparable treatment to heart transplantation

Feature | Artificial Heart | By Francisco Arabia, MD, MBA

Next-Generation Total Artificial Hearts Offer New Hope for Heart Failure Patients

The U.S. organ donation system has long been under scrutiny, with questions about fairness in organ allocation and ...

July 20, 2023

The U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers recommending that health care providers, laboratory personnel, and facilities stop using the Quidel Triage Cardiac Panel, manufactured by Quidel Cardiovascular Inc. (QuidelOrtho), and use an alternative method, or an alternate local testing site if available.

News | Heart Failure

FDA Issues Letter to Healthcare Providers on Using Alternative Testing Method for Quidel Triage Cardiac Pane

July 19, 2023 — The U.S. Food and Drug Administration (FDA) is recommending health care providers, laboratory personnel ...

July 19, 2023

The proposed approach outperforms other neural network architectures by leveraging rich geometric information to segment brain stroke lesion images

News | Stroke

New Geometric Deep Learning Model for Detecting Stroke Lesions

July 19, 2023 — Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a clot, is among the ...

July 19, 2023

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

EU Physicians have successfully treated the first patients using the combined benefits of Abbott’s Ensite X Mapping System and Stereotaxis’ Robotic Magnetic Navigation System

News | Robotic Systems

Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients

July 19, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

July 19, 2023

Medtronic is recalling all ICDs and CRT-Ds, manufactured after 2017, with a glassed feedthrough as they may deliver low or no energy output when needed for high voltage therapy.

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Recalls ICDs and CRT-Ds for Risk of Low or No Energy Output During High Voltage Therapy

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

July 18, 2023

Quidel Cardiovascular is recalling its Quidel Triage Cardiac Panels for risk of false negative troponin results that could cause delayed diagnosis or missed myocardial infarction

News | Heart Failure

Quidel Cardiovascular Inc. Recalls Quidel Triage Cardiac Panels for Risk of False Negative Troponin Results

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on Quidel Cardiovascular is ...

July 18, 2023

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention

News | Artificial Intelligence

AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

July 18, 2023

Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases

News | Cardiovascular Business

Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases

July 14, 2023 — Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire ...

July 14, 2023

No statistical difference observed across sub-analyses for diabetes, lesion length, calcium, bailout stenting and occlusions in head-to-head study comparing Passeo-18 Lux DCB to In.Pact Admiral DCB

News | Drug-Eluting Balloons

BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon

July 14, 2023 — BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized ...

July 14, 2023

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Illustration for the deployment and shaping process of the occluder.

News | Structural Heart Occluders

Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

July 14, 2023

Feature | Information Technology | By Melinda Taschetta-Millane

One on One ... With Anne Snowdon, RN, PhD, FAAN

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this ...

July 14, 2023

New service will provide rapid and comprehensive care to hundreds of heart patients every year for life-threatening emergencies and scheduled cardiac procedures.

News | Cath Lab

Mount Sinai Queens Opens New Cardiac Catheterization Lab to Expedite Care for Heart Attack Patients

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

July 13, 2023